http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102861337-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-185 |
| filingDate | 2012-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102861337-B |
| titleOfInvention | One kind contains solid formulation of egualen sodium |
| abstract | One kind contains solid formulation of egualen sodium, it is that egualen sodium and a kind of bisfentidine are active component, it is mixed with more than one the additive selected from PVP and its derivative and alkalinity additive simultaneously, oral solid formulation, and the purposes in treatment gastric ulcer, duodenal ulcer, gastroesophageal reflux medicine is prepared are made by certain preparation technology. |
| priorityDate | 2012-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 130.